Annual Current Liabilities
$2.60 M
-$10.56 M-80.27%
December 31, 2023
Summary
- As of February 8, 2025, CRVO annual total current liabilities is $2.60 million, with the most recent change of -$10.56 million (-80.27%) on December 31, 2023.
- During the last 3 years, CRVO annual current liabilities has risen by +$159.90 thousand (+6.56%).
- CRVO annual current liabilities is now -87.55% below its all-time high of $20.85 million, reached on December 1, 2012.
Performance
CRVO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$3.25 M
+$32.70 K+1.02%
September 30, 2024
Summary
- As of February 8, 2025, CRVO quarterly total current liabilities is $3.25 million, with the most recent change of +$32.70 thousand (+1.02%) on September 30, 2024.
- Over the past year, CRVO quarterly current liabilities has increased by +$585.30 thousand (+21.99%).
- CRVO quarterly current liabilities is now -93.71% below its all-time high of $51.60 million, reached on March 1, 2017.
Performance
CRVO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
CRVO Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -80.3% | +22.0% |
3 y3 years | +6.6% | +22.0% |
5 y5 years | +222.8% | +22.0% |
CRVO Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -80.3% | at low | -75.3% | +121.6% |
5 y | 5-year | -80.3% | +50.8% | -75.3% | +152.3% |
alltime | all time | -87.5% | +2635.2% | -93.7% | +2170.2% |
CervoMed Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $3.25 M(+1.0%) |
Jun 2024 | - | $3.21 M(+20.8%) |
Mar 2024 | - | $2.66 M(+2.5%) |
Dec 2023 | $2.60 M(-80.3%) | $2.60 M(+5.4%) |
Sep 2023 | - | $2.46 M(+68.2%) |
Jun 2023 | - | $1.47 M(-31.1%) |
Mar 2023 | - | $2.13 M(-83.8%) |
Dec 2022 | $13.16 M(+349.3%) | - |
Dec 2022 | - | $13.16 M(+479.4%) |
Sep 2022 | - | $2.27 M(-9.7%) |
Jun 2022 | - | $2.52 M(-14.9%) |
Mar 2022 | - | $2.96 M(+1.0%) |
Dec 2021 | $2.93 M(+20.2%) | $2.93 M(+6.5%) |
Sep 2021 | - | $2.75 M(+30.9%) |
Jun 2021 | - | $2.10 M(-0.6%) |
Mar 2021 | - | $2.11 M(-13.2%) |
Dec 2020 | $2.44 M(+41.5%) | $2.44 M(-9.3%) |
Sep 2020 | - | $2.69 M(+50.8%) |
Jun 2020 | - | $1.78 M(+38.5%) |
Mar 2020 | - | $1.29 M(-25.2%) |
Dec 2019 | $1.72 M(+114.1%) | $1.72 M(+41.3%) |
Sep 2019 | - | $1.22 M(+16.8%) |
Jun 2019 | - | $1.04 M(-12.6%) |
Mar 2019 | - | $1.19 M(+48.4%) |
Dec 2018 | $804.00 K(-70.1%) | $804.00 K(-15.0%) |
Sep 2018 | - | $945.70 K(+37.5%) |
Jun 2018 | - | $688.00 K(-51.6%) |
Mar 2018 | - | $1.42 M(-47.1%) |
Dec 2017 | $2.69 M(-39.4%) | $2.69 M(-85.6%) |
Sep 2017 | - | $18.69 M(-36.6%) |
Jun 2017 | - | $29.46 M(-42.9%) |
Mar 2017 | - | $51.60 M(+1062.6%) |
Dec 2016 | $4.44 M(+201.7%) | $4.44 M(+20.6%) |
Sep 2016 | - | $3.68 M(+109.5%) |
Jun 2016 | - | $1.76 M(-20.4%) |
Mar 2016 | - | $2.21 M(+50.0%) |
Dec 2015 | $1.47 M | $1.47 M(-27.7%) |
Sep 2015 | - | $2.03 M(-20.8%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2015 | - | $2.57 M(+22.7%) |
Mar 2015 | - | $2.09 M(-10.5%) |
Dec 2014 | $2.34 M(-73.7%) | $2.34 M(-21.4%) |
Sep 2014 | - | $2.98 M(-27.9%) |
Jun 2014 | - | $4.13 M(-61.4%) |
Mar 2014 | - | $10.69 M(+20.5%) |
Dec 2013 | $8.88 M(-57.4%) | $8.88 M(-7.2%) |
Sep 2013 | - | $9.57 M(+9.2%) |
Jun 2013 | - | $8.77 M(-60.0%) |
Mar 2013 | - | $21.92 M(+5.1%) |
Dec 2012 | $20.85 M(+6.0%) | $20.85 M(+108.9%) |
Sep 2012 | - | $9.98 M(+13.7%) |
Jun 2012 | - | $8.78 M(+52.2%) |
Mar 2012 | - | $5.77 M(-70.7%) |
Dec 2011 | $19.68 M(+299.1%) | $19.68 M(+489.5%) |
Sep 2011 | - | $3.34 M(+4.7%) |
Jun 2011 | - | $3.19 M(-42.5%) |
Mar 2011 | - | $5.55 M(+12.5%) |
Dec 2010 | $4.93 M(+55.8%) | $4.93 M(+24.4%) |
Sep 2010 | - | $3.96 M(+5.4%) |
Jun 2010 | - | $3.76 M(+8.1%) |
Mar 2010 | - | $3.48 M(+10.0%) |
Dec 2009 | $3.16 M(-26.4%) | $3.16 M(-32.0%) |
Sep 2009 | - | $4.65 M(+4.4%) |
Jun 2009 | - | $4.46 M(+9.4%) |
Mar 2009 | - | $4.08 M(-5.2%) |
Dec 2008 | $4.30 M(-35.0%) | $4.30 M(-35.2%) |
Sep 2008 | - | $6.63 M(+2.4%) |
Jun 2008 | - | $6.48 M(+0.8%) |
Mar 2008 | - | $6.43 M(-2.7%) |
Dec 2007 | $6.61 M(+4521.7%) | $6.61 M(+3144.5%) |
Sep 2007 | - | $203.70 K(+6.6%) |
Jun 2007 | - | $191.00 K(+28.9%) |
Mar 2007 | - | $148.20 K(+3.6%) |
Dec 2006 | $143.00 K(+50.7%) | $143.00 K |
Dec 2005 | $94.90 K(-99.4%) | - |
Dec 1999 | $16.76 M(+256.7%) | - |
Dec 1998 | $4.70 M | - |
FAQ
- What is CervoMed annual total current liabilities?
- What is the all time high annual current liabilities for CervoMed?
- What is CervoMed annual current liabilities year-on-year change?
- What is CervoMed quarterly total current liabilities?
- What is the all time high quarterly current liabilities for CervoMed?
- What is CervoMed quarterly current liabilities year-on-year change?
What is CervoMed annual total current liabilities?
The current annual current liabilities of CRVO is $2.60 M
What is the all time high annual current liabilities for CervoMed?
CervoMed all-time high annual total current liabilities is $20.85 M
What is CervoMed annual current liabilities year-on-year change?
Over the past year, CRVO annual total current liabilities has changed by -$10.56 M (-80.27%)
What is CervoMed quarterly total current liabilities?
The current quarterly current liabilities of CRVO is $3.25 M
What is the all time high quarterly current liabilities for CervoMed?
CervoMed all-time high quarterly total current liabilities is $51.60 M
What is CervoMed quarterly current liabilities year-on-year change?
Over the past year, CRVO quarterly total current liabilities has changed by +$585.30 K (+21.99%)